NYSE - Nasdaq Real Time Price USD

Inspire Medical Systems, Inc. (INSP)

155.22 -3.81 (-2.40%)
At close: May 17 at 4:00 PM EDT
154.87 -0.35 (-0.23%)
After hours: May 17 at 7:59 PM EDT
Loading Chart for INSP
DELL
  • Previous Close 159.03
  • Open 159.48
  • Bid 154.87 x 1000
  • Ask 155.88 x 900
  • Day's Range 152.90 - 159.48
  • 52 Week Range 123.27 - 330.00
  • Volume 759,005
  • Avg. Volume 577,233
  • Market Cap (intraday) 4.612B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.53
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 252.56

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,011

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INSP

Performance Overview: INSP

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INSP
23.70%
S&P 500
11.18%

1-Year Return

INSP
48.01%
S&P 500
29.04%

3-Year Return

INSP
9.31%
S&P 500
27.06%

5-Year Return

INSP
191.06%
S&P 500
84.38%

Compare To: INSP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INSP

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    4.61B

  • Enterprise Value

    4.19B

  • Trailing P/E

    --

  • Forward P/E

    909.09

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.91

  • Price/Book (mrq)

    7.83

  • Enterprise Value/Revenue

    6.35

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.38%

  • Return on Assets (ttm)

    -3.58%

  • Return on Equity (ttm)

    -2.88%

  • Revenue (ttm)

    660.91M

  • Net Income Avi to Common (ttm)

    -15.73M

  • Diluted EPS (ttm)

    -0.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    441.36M

  • Total Debt/Equity (mrq)

    4.16%

  • Levered Free Cash Flow (ttm)

    4.29M

Research Analysis: INSP

Company Insights: INSP

Research Reports: INSP

People Also Watch